The bioflavonoid troxerutin prevents gestational hypertension in mice by inhibiting stat3 signaling

The bioflavonoid troxerutin prevents gestational hypertension in mice by inhibiting stat3 signaling

Play all audios:

Loading...

ABSTRACT Gestational hypertension is a high-risk disease for women, and the current treatments have limited efficacies. Here, we aimed to evaluate troxerutin, which is a natural monomer of


flavone, in the treatment of gestational hypertension. Pregnant mice with or without pregnancy-induced hypertension (PIH) were treated with troxerutin (20 and 40 mg/kg) or vehicle. Blood


pressure and proteinuria were monitored during treatment. The expression of vasodilation converting enzyme (VCE), angiotensin, TNFα, IL-6, IL-1β and IL-10 was measured by enzyme-linked


immunosorbent assay (ELISA). Oxidative stress was assessed by measuring the reactive oxygen species (ROS) levels and antioxidant enzyme concentrations. Western blot analysis was used to


assess the expression of p-STAT3, STAT3, SHP-1, and RNF6. Troxerutin reduced blood pressure and the expression of VCE, angiotensin, urinary protein and pro-inflammatory cytokines in a


dose-dependent manner while increasing the expression of anti-inflammatory cytokines. The levels of ROS were decreased, and the levels of antioxidant enzymes were increased. Troxerutin


treatment significantly suppressed STAT3/RNF6 signaling. Overexpression of RNF6 attenuated the effects of troxerutin in ameliorating inflammation and oxidative stress. Our data support the


use of troxerutin for reducing gestational hypertension due to the role of troxerutin in reducing inflammation and oxidative stress. Access through your institution Buy or subscribe This is


a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $259.00 per


year only $21.58 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated


during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS CROCIN


EXHIBITS AN ANTIHYPERTENSIVE EFFECT IN A RAT MODEL OF GESTATIONAL HYPERTENSION AND ACTIVATES THE NRF-2/HO-1 SIGNALING PATHWAY Article 13 January 2021 QUERCETIN ALLEVIATES ENDOTHELIAL


DYSFUNCTION IN PREECLAMPSIA BY INHIBITING FERROPTOSIS AND INFLAMMATION THROUGH EGFR BINDING Article Open access 20 January 2025 PHARMACOLOGICAL AND TOXICOLOGICAL EFFECTS OF JIANGFANGBAOXIN


AND DETERMINATION OF ITS COMPONENTS IN THE BLOOD OF SPONTANEOUSLY HYPERTENSIVE RATS Article Open access 10 February 2025 REFERENCES * Theilen LH, Fraser A, Hollingshaus MS, Schliep KC,


Varner MW, Smith KR, et al. All-cause and cause-specific mortality after hypertensive disease of pregnancy. Obstet Gynecol. 2016;128:238. Article  Google Scholar  * Chen Z, Du J, Shao L,


Zheng L, Wu M, Ai M, et al. Prepregnancy body mass index, gestational weight gain, and pregnancy outcomes in China. Int J Gynecol Obstet. 2010;109:41–4. Article  Google Scholar  * Folk DM.


Hypertensive disorders of pregnancy: overview and current recommendations. J Midwifery Women’s Health. 2018;63:289–300. Article  Google Scholar  * Shen M, Smith GN, Rodger M, White RR,


Walker MC, Wen SW. Comparison of risk factors and outcomes of gestational hypertension and pre-eclampsia. PLoS ONE. 2017;12:e0175914. Article  Google Scholar  * Huang Q, Hu BH, Han XJ, Yang


JY, Di XD, Bao JJ, et al. Cyclosporin A ameliorates eclampsia seizure through reducing systemic inflammation in an eclampsia-like rat model. Hypertens Res. 2020;43:263–70. Article  CAS 


Google Scholar  * Clark JL, Zahradka P, Taylor CG. Efficacy of flavonoids in the management of high blood pressure. Nutr Rev. 2015;73:799–822. Article  Google Scholar  * de Jesus


Romero-Prado MM, Curiel-Beltran JA, Miramontes-Espino MV, Cardona-Munoz EG, Rios-Arellano A, Balam-Salazar LB. Dietary flavonoids added to pharmacological antihypertensive therapy are


effective in improving blood pressure. Basic Clin Pharm Toxicol. 2015;117:57–64. Article  Google Scholar  * Knekt P, Kumpulainen J, Jarvinen R, Rissanen H, Heliovaara M, Reunanen A, et al.


Flavonoid intake and risk of chronic diseases. Am J Clin Nutr. 2002;76:560–8. Article  CAS  Google Scholar  * Panat NA, Singh BG, Maurya DK, Sandur SK, Ghaskadbi SS. Troxerutin, a natural


flavonoid binds to DNA minor groove and enhances cancer cell killing in response to radiation. Chem-Biol Interact. 2016;251:34–44. Article  CAS  Google Scholar  * Maurya DK, Salvi VP, Nair


CKK. Radioprotection of normal tissues in tumor-bearing mice by troxerutin. J Radiat Res. 2004;45:221–8. Article  CAS  Google Scholar  * Geetha R, Radika MK, Priyadarshini E, Bhavani K,


Anuradha CV. Troxerutin reverses fibrotic changes in the myocardium of high-fat high-fructose diet-fed mice. Mol Cell Biochem. 2015;407:263–79. Article  CAS  Google Scholar  * Raja B,


Saranya D, Prabhu R. Role of flavonoid troxerutin on blood pressure, oxidative stress and regulation of lipid metabolism. Front Biosci (Elite Ed). 2019;11:121–9. Article  Google Scholar  *


Paulin R, Meloche J, Bonnet S. STAT3 signaling in pulmonary arterial hypertension. Jak-Stat. 2012;1:223–33. Article  Google Scholar  * Bromberg J, Wang TC. Inflammation and cancer: IL-6 and


STAT3 complete the link. Cancer Cell. 2009;15:79–80. Article  CAS  Google Scholar  * Armstrong DW, Tse MY, O’Tierney-Ginn PF, Wong PG, Ventura NM, Janzen-Pang JJ, et al. Gestational


hypertension in atrial natriuretic peptide knockout mice and the developmental origins of salt-sensitivity and cardiac hypertrophy. Regulatory Pept. 2013;186:108–15. Article  CAS  Google


Scholar  * Vinothkumar R, Vinoth Kumar R, Sudha M, Viswanathan P, Balasubramanian T, Nalini N. Modulatory effect of troxerutin on biotransforming enzymes and preneoplasic lesions induced by


1,2-dimethylhydrazine in rat colon carcinogenesis. Exp Mol Pathol. 2014;96:15–26. Article  CAS  Google Scholar  * Hoseindoost M, Alipour MR, Farajdokht F, Diba R, Bayandor P, Mehri K, et al.


Effects of troxerutin on inflammatory cytokines and BDNF levels in male offspring of high-fat diet fed rats. Avicenna J Phytomedicine. 2019;9:597–605. CAS  Google Scholar  * Zhao X, Wang X.


Candesartan targeting of angiotensin II type 1 receptor demonstrates benefits for hypertension in pregnancy via the NF‑κB signaling pathway. Mol Med Rep. 2018;18:705–14. CAS  PubMed  PubMed


Central  Google Scholar  * Sui R, Zang L, Bai Y. Administration of troxerutin and cerebroprotein hydrolysate injection alleviates cerebral ischemia/reperfusion injury by down-regulating


caspase molecules. Neuropsychiatr Dis Treat. 2019;15:2345. Article  CAS  Google Scholar  * Jamali-Raeufy N, Kardgar S, Baluchnejadmojarad T, Roghani M, Goudarzi M. Troxerutin exerts


neuroprotection against lipopolysaccharide (LPS) induced oxidative stress and neuroinflammation through targeting SIRT1/SIRT3 signaling pathway. Metab Brain Dis. 2019;34:1505–13. Article 


CAS  Google Scholar  * Ji JZ, Elyaman W, Yip HK, Lee VW, Yick LW, Hugon J, et al. CNTF promotes survival of retinal ganglion cells after induction of ocular hypertension in rats: the


possible involvement of STAT3 pathway. Eur J Neurosci. 2004;19:265–72. Article  Google Scholar  * Zhang Z, Yang X, Zhang L, Duan Z, Jia L, Wang P, et al. Decreased expression and activation


of Stat3 in severe preeclampsia. J Mol Histol. 2015;46:205–19. Article  Google Scholar  * Hodge DR, Hurt EM, Farrar WL. The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer.


2005;41:2502–12. Article  CAS  Google Scholar  * Huang ZM, Cai Y, Yang CC, Chen Z, Sun H, Xu Y, et al. Knockdown of RNF6 inhibits gastric cancer cell growth by suppressing STAT3 signaling.


Oncotargets Ther. 2018;11:6579–86. Article  CAS  Google Scholar  * Subastri A, Harikrishna K, Sureshkumar M, Alshammari GM, Aristatile B, Thirunavukkarasu C. Effect of troxerutin on


2-aminoanthracene and DNA interaction and its anti-mutagenic property. Biomed Pharmacother. 2017;88:325–34. Article  CAS  Google Scholar  Download references AUTHOR INFORMATION AUTHORS AND


AFFILIATIONS * Department of Obstetrics, Zibo Central Hospital, No. 54 of Gongqingtuan West Road, Zhangdian District, Zibo, 255000, Shandong Province, China Yuan Li, Xiuzhi Yang & Bide


Duan * Department of Scientific Education and Communication Cooperation, Zibo Central Hospital, No. 54 of Gongqingtuan West Road, Zhangdian District, Zibo, 255000, Shandong Province, China


Qi Sun * Department of Obstetrics and Gynecology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, No. 324 Jingwu Road, Jinan, 250021, Shandong, China Yanyun


Wang Authors * Yuan Li View author publications You can also search for this author inPubMed Google Scholar * Xiuzhi Yang View author publications You can also search for this author


inPubMed Google Scholar * Qi Sun View author publications You can also search for this author inPubMed Google Scholar * Bide Duan View author publications You can also search for this author


inPubMed Google Scholar * Yanyun Wang View author publications You can also search for this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to Yanyun Wang. ETHICS


DECLARATIONS CONFLICT OF INTEREST The authors declare that they have no conflict of interest. ADDITIONAL INFORMATION PUBLISHER’S NOTE Springer Nature remains neutral with regard to


jurisdictional claims in published maps and institutional affiliations. SUPPLEMENTARY INFORMATION SUPPLEMENTARY MATERIALS RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE


CITE THIS ARTICLE Li, Y., Yang, X., Sun, Q. _et al._ The bioflavonoid troxerutin prevents gestational hypertension in mice by inhibiting STAT3 signaling. _Hypertens Res_ 44, 399–406 (2021).


https://doi.org/10.1038/s41440-020-00568-z Download citation * Received: 26 April 2020 * Revised: 13 August 2020 * Accepted: 23 September 2020 * Published: 30 October 2020 * Issue Date:


April 2021 * DOI: https://doi.org/10.1038/s41440-020-00568-z SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a


shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative KEYWORDS * Troxerutin * Gestational


hypertension * Inflammation * Oxidative stress